Herduo 250mg
In stock
Description
Herduo 250mg Tablet contains Lapatinib, a targeted kinase inhibitor used to treat HER2-positive advanced or metastatic breast cancer. It works by blocking epidermal growth factor receptors (HER2 and EGFR), interrupting signaling pathways that cause cancer cell growth, and promoting apoptosis. It is typically taken on an empty stomach.
Specifications
| Strength | 250 mg |
|---|---|
| Form | Tablet |
| Drug Class | Kinase Inhibitors / Tyrosine Kinase Inhibitor (TKI) |
| Uses | Breast cancer treatment |
| Main Ingredients | Lapatinib |
| Administration | Oral |
